News & Perspective

Aug 15, 2017

Aug 15, 2017
Tamiflu macro

ECDC experts confirm support for neuraminidase inhibitors

The review didn't find any new evidence to drive policy changes, but said more research and new antivirals are needed.

Jul 20, 2017

Jul 20, 2017
AIDS researcher

Report details economic benefits of US global health R & D

The study says the funding has spurred growth of US jobs while bringing lifesaving products to the world.

May 23, 2017

May 23, 2017
Federal budget

White House budget proposal spells steep cuts for public health

Though deep cuts aren't likely to be enacted, health groups and experts aired strong concerns.

Mar 30, 2017

Mar 30, 2017
Scientist in laboratory

CARB-X awards $24 million for new antibacterial products

The products include 3 new classes of small-molecule antibiotics.

Mar 16, 2017

Mar 16, 2017
NIH researcher

Trump's budget cuts 20% of NIH; groups express outrage

The budget supports earlier commitment to Gavi vaccine initiatives but dials back funds for other global health efforts.

Feb 28, 2017

Feb 28, 2017

News Scan for Feb 28, 2017

Zika study rejected
Asymptomatic Ebola
MERS cases
CEPI names CEO
Biosecurity lab in China

Sep 30, 2014

Sep 30, 2014

News Scan for Sep 30, 2014

MERS in Austria
Hospital C diff rise
Vaccine adjuvant research
Countermeasures in emergencies

Jan 23, 2013

Jan 23, 2013

Research moratorium on modified H5N1 viruses ends

(CIDRAP News) – A year-long voluntary moratorium on research involving transmissible H5N1 avian flu viruses ended today with a letter from a group of scientists that supports resuming the work in countries that have addressed the biosafety issues involved.

Pages

Sort Results

 

Narrow results

by Topic

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3M Gilead 
Grant support for ASP provided by

  Become an underwriter»